Impact of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines on the Next Blood Pressure Guidelines in Asia

  • Naoki NakagawaEmail author
  • Naoyuki Hasebe
Prevention of Hypertension: Public Health Challenges (Yuichiro Yano, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Prevention of Hypertension: Public Health Challenges


Purpose of Review

To estimate the impact of the 2017 American College of Cardiology/American Heart Association (ACC/AHA) guidelines for high blood pressure (BP) on the next hypertension guidelines in Asia.

Recent Findings

The 2017 ACC/AHA guidelines for high BP in adults changed the diagnostic threshold and the management goal of BP from 140/90 to 130/80 mmHg. Another characteristic of the new guideline is its focus on a practical approach for the effective management of hypertension by using home and ambulatory BP monitoring; this point is also recommended in the 2014 Japanese Society of Hypertension Guidelines for the Management of Hypertension.


In Japan, the guidelines for hypertension management are currently under revision and will be released in the spring of 2019. The core concept of the 2019 Japanese Society of Hypertension Guidelines for the Management of Hypertension, i.e., early and tight BP control over 24 h, will contribute to target-organ protection and cardiovascular disease prevention for Asians.


Ambulatory blood pressure monitoring Blood pressure Ethnic differences Guideline Hypertension Paradox 


Compliance with Ethical Standards

Conflict of Interest

The authors declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


  1. 1.
    Kario K. Global impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: a perspective from Japan. Circulation. 2018;137(6):543–5. Scholar
  2. 2.
    Wang JG, Liu L. Global impact of 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: a perspective from China. Circulation. 2018;137(6):546–8. Scholar
  3. 3.
    Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13–e115. Scholar
  4. 4.
    Kario K, Chen CH, Park S, Park CG, Hoshide S, Cheng HM, et al. Consensus document on improving hypertension management in Asian patients, taking into account Asian characteristics. Hypertension. 2018;71(3):375–82. Scholar
  5. 5.
    Kario K, Saito I, Kushiro T, Teramukai S, Ishikawa Y, Mori Y, et al. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study. Hypertension. 2014;64(5):989–96. Scholar
  6. 6.
    Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12. Scholar
  7. 7.
    Ishikawa Y, Ishikawa J, Ishikawa S, Kayaba K, Nakamura Y, Shimada K, et al. Prevalence and determinants of prehypertension in a Japanese general population: the Jichi Medical School Cohort Study. Hypertens Res. 2008;31(7):1323–30. Scholar
  8. 8.
    Kario K. Key points of the Japanese Society of Hypertension Guidelines for the Management of Hypertension in 2014. Pulse (Basel). 2015;3(1):35–47. Scholar
  9. 9.
    Nakano M, Eguchi K, Sato T, Onoguchi A, Hoshide S, Kario K. Effect of intensive salt-restriction education on clinic, home, and ambulatory blood pressure levels in treated hypertensive patients during a 3-month education period. J Clin Hypertens (Greenwich). 2016;18(5):385–92. Scholar
  10. 10.
    Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37(4):253–390. Scholar
  11. 11.
    Yano Y, Oparil S. Masked hypertension. Curr Hypertens Rep. 2017;19(10):81. Scholar
  12. 12.
    Kario K. Evidence and perspectives on the 24-hour management of hypertension: hemodynamic biomarker-initiated ‘Anticipation Medicine’ for zero cardiovascular event. Prog Cardiovasc Dis. 2016;59(3):262–81. Scholar
  13. 13.
    Kario K, Tomitani N, Kanegae H, Yasui N, Nishizawa M, Fujiwara T, et al. Development of a new ICT-based multisensor blood pressure monitoring system for use in hemodynamic biomarker-initiated anticipation medicine for cardiovascular disease: the national IMPACT program project. Prog Cardiovasc Dis. 2017;60(3):435–49. Scholar
  14. 14.
    Kario K. Perfect 24-h management of hypertension: clinical relevance and perspectives. J Hum Hypertens. 2017;31(4):231–43. Scholar
  15. 15.
    Omboni S, Aristizabal D, De la Sierra A, Dolan E, Head G, Kahan T, et al. Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study. J Hypertens. 2016;34(11):2187–98. Scholar
  16. 16.
    Hoshide S, Kario K, de la Sierra A, Bilo G, Schillaci G, Banegas JR, et al. Ethnic differences in the degree of morning blood pressure surge and in its determinants between Japanese and European hypertensive subjects: data from the ARTEMIS study. Hypertension. 2015;66(4):750–6. Scholar
  17. 17.
    Li Y, Wang JG. Isolated nocturnal hypertension: a disease masked in the dark. Hypertension. 2013;61(2):278–83. Scholar
  18. 18.
    Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Bjorklund-Bodegard K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370(9594):1219–29. Scholar
  19. 19.
    Wang JG, Kario K, Chen CH, Park JB, Hoshide S, Huo Y, et al. Management of morning hypertension: a consensus statement of an Asian expert panel. J Clin Hypertens (Greenwich). 2018;20(1):39–44. Scholar
  20. 20.
    Nakagawa N, Hasebe N. Impact of mild-to-moderate alcohol consumption and smoking on kidney function. Hypertens Res. 2017;40(9):809–10. Scholar
  21. 21.
    Fujiwara T, Hoshide S, Kanegae H, Nishizawa M, Kario K. Reliability of morning, before-dinner, and at-bedtime home blood pressure measurements in patients with hypertension. J Clin Hypertens (Greenwich). 2018;20(2):315–23. Scholar
  22. 22.
    Kario K, Wang JG. Could 130/80 mm Hg be adopted as the diagnostic threshold and management goal of hypertension in consideration of the characteristics of Asian populations? Hypertension. 2018;71(6):979–84. Scholar
  23. 23.
    Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - the JNC 7 report. JAMA. 2003;289(19):2560–72.CrossRefGoogle Scholar
  24. 24.
    Chobanian AV. Shattuck Lecture. The Hypertension Paradox--more uncontrolled disease despite improved therapy. N Engl J Med. 2009;361(9):878–87. Scholar
  25. 25.
    Konta T, Ikeda A, Ichikawa K, Fujimoto S, Iseki K, Moriyama T, et al. Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort. Am J Hypertens. 2012;25(3):342–7. Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of Cardiology, Nephrology, Pulmonology and Neurology, Department of Internal MedicineAsahikawa Medical UniversityAsahikawaJapan

Personalised recommendations